Neural Analytics, the Los Angeles based company that won FDA clearance a couple of years ago for its Lucid M1 Transcranial Doppler Ultrasound System, now won another clearance, this time for its NeuralBot robotic ultrasound positioner. The two devices work together and when united will be called the Lucid Robotic System.
The NeuralBot automatically positions the ultrasound probe, with some help from a clinician, to achieve the optimal results when scanning the brain for signs of neurological conditions. Similar procedures have been available before, but a trained professionals were required to properly perform and analyze the results. The new offerings can help to make this a lot easier and potentially even allow emergency rooms to quickly scan patients for stroke or other brain conditions.
“Progress in treating neurological disorders has lagged due to a lack of available low-cost and objective patient diagnostic information. This has resulted in misdiagnosis, treatment delays and additional healthcare expenditures for patients suffering neurological disease,” said Robert Hamilton, Ph.D., Co-Founder and Chief Scientific Officer of Neural Analytics. “Our new technology can assist a healthcare professional- when an expert technician is not available – with the collection of blood flow data to assist clinicians in efficiently triaging patients for appropriate treatment.”
The company hopes that soon paramedics will have access to its Lucid Robotic System to assess patients for stroke right in the field.
Here’s a silent video from Neural Analytics describing its technology:
Flashbacks: Lucid M1 Brain Damage Assessment Transcranial Doppler Ultrasound System Now Available…; Lucid M1 Ultrasound Brain Damage Assessment System Cleared by FDA…
Link: Neural Analytics homepage…
Via: Neural Analytics…
